4.25 (-%)
As of Nov 04, 2024
Source:
Omeros Corp is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders.
Country | United States |
Headquarters | seattle, washington |
Phone Number | 206-676-5000 |
Industry | manufacturing |
CEO | Gregory A. Demopulos |
Website | www.omeros.com |